The Journal of Organic Chemistry
Article
Me P and Bu P reactions and 20 h for Ph P reaction and then
3
3
3
thioanisole/TIS/H O (88:2:5:5, 2 mL). The mixture was filtered,
and the resin was rinsed with an additional cleavage cocktail. The
analyzed by analytical HPLC (linear gradient of 5% ACN/95% H O
2
2
combined filtrates were concentrated to one-fourth the original
volume using a stream of N gas. The peptide was precipitated by
Reaction of Peptide 31 with Excess PBu in the Presence of
2
3
adding cold ether (3 mL). The precipitated peptide (white precipitate)
was collected by centrifugation and washed with cold ether (2×). The
an Excess Amount of the Symmetric Anhydride of FmocGlu-
(
OtBu)OH and Water. A solution of the symmetric anhydride of
FmocGlu(OtBu)OH in dry THF (2 mL, 5 equiv) was added to
peptide 31 (0.023 g, 0.030 mmol) followed by 3 equiv of Bu P and
3
stirred for 5 min. H O (0.1 mL) was added, and the mixture was
Reaction of N Trp(Boc)OH with PPh . To a solution of
2
3
3
stirred for 18 h. An aliquot was withdrawn from the reaction mixture,
N Trp(Boc)OH (0.200 g, 0.61 mmol) in dry ether (4 mL) was
3
added a solution of PPh (0.159g, 0.61 mmol) in dry ether (2 mL).
3
2
3
(
Synthesis of Dap-E12-W13 Starting from Peptide 4. To
The mixture was stirred at rt for 2 h and filtered. The filter cake was
washed with ether and dried under high vacuum, yielding a white solid
peptide 4 (0.025 mmol) was added a solution of 5 equiv of the
symmetric anhydride of FmocGlu(OtBu)OH in THF (0.5 mL)
(
0.102 g, 30%). The analytical HPLC chromatogram of this precipitate
shows one major peak with t = 36.6 min as well as well as a few very
r
followed by Bu P (3 equiv). The mixture was agitated for 5 min, and
3
3
3
1
H O (0.1 mL) was added and the mixture agitated for 18 h. The
2
Information): H NMR (CDCl ) δ 8.10 (1H, d, J = 8.4 Hz), 7.60 (1H,
3
mixture was filtered and washed with DMF (3×) and DCM (3×).
FmocGlu(OtBu)OH and Fmoc-D-Ser(OtBu)OH were incorporated
using standard Fmoc SPPS techniques employing DIC/HOBt as
coupling agents (3.5 h) and 20% 2-methylpiperidine/DMF (3 × 10
min) for Fmoc removal. The alloc group was removed using DMBA
(dimethylbarbituric acid, 10 equiv) in the presence of a catalytic
amount of Pd(PPh ) in DCM/DMF (3:1 v/v) for 1 h. After filtration,
the resin was washed with DCM (3×) and a 1.0% solution of sodium
diethyldithiocarbamate trihydrate in DMF (3×) to remove excess Pd
catalyst and then DCM (3×) and DMF (3×). On-resin cyclization was
performed using PyAOP/HOAt/2,4,6-collidine (5/5/10 equiv) in the
presence of 1% Triton X-100 in DMF (2 mL) (2 × 1.5 h). Crude Dap-
E12-W13 was obtained by treating peptide 47 with a solution of TFA/
d, J = 7.4 Hz), 7.47 (1H, s), 7.19−7.40 (19H, m), 4.17 (1H, ddd, J =
1
1
1
0.6, 9.0, 3.2 Hz), 3.15 (1H, dd, J = 14.8, 3.2 Hz), 3.14 (1H, dd, J =
4.8, 9.0 Hz), 1.63 (9H, s); 13C NMR (CDCl ) δ 172.3, 149.4, 135.4,
3
34.4, 133.6 (d, J = 19.5 Hz), 131.4 (d, J = 10.8 Hz), 131, 130.4, 128.3
(
3
5
d, J = 14.1 Hz), 124.5, 124.0, 122.5, 119.2, 116.8, 115.2, 83.5, 56.2,
31
0.0, 28.1; P NMR (CDCl ) δ −10.9, −2.8 (PPh ), 31.7 (POPh ),
3
3
3
1.2; 3 P NMR (THF) δ −39.4, −0.4 (PPh ), 23.8 (POPh );
1
3
1
P
3 4
3
3
NMR (THF/10% H O) δ 2.05, 27.5 (POPh ); HRMS (m/z) [M +
H] calcd for C H O N P 565.22507; found 565.22446. The HPLC
2
3
+
34
34
4
2
chromatogram of a mixture of this precipitate with compound 21/24
isolated from filtrate #1 in the reaction of peptide 4 with PPh in
3
2
thioanisole/TIS/H O (88:2:5:5, 2 mL) for 2 h. The mixture was
Reaction of Peptide 4 with Excess PBu in the Presence of
2
3
the Symmetric Anhydride of FmocGlu(OtBu)OH and Water.
The symmetric anhydride of FmocGlu(OtBu)OH was prepared by
stirring FmocGlu(OtBu)OH (0.25 mmol) and DIC (0.125 mmol) in
filtered, and the resin was rinsed with an additional cleavage cocktail.
The combined filtrates were concentrated to one-fourth the original
volume using a stream of N gas. The peptide was precipitated by
2
adding cold ether (3 mL). The precipitated peptide was collected by
centrifugation and washed with cold ether (2×). Pure Dap-E12-W13
was obtained using semipreparative HPLC employing a linear gradient
32
dry THF (2 mL) for 1 h at rt. The mixture was filtered. The filtrate
was added to peptide 4 (0.025 mmol), followed by Bu P (3 equiv),
3
and agitated for 5 min. H O (0.1 mL) was added, and the mixture was
2
agitated for 18 h. The resin was washed with DMF (3×) and DCM
of 35:65 CH CN/H O (0.1% TFA) to 43:57 CH CN/H O (0.1%
3 2 3 2
(
3×) and then treated with TFA/thioanisole/TIS/H O (88:2:5:5, 2
TFA) over 60 min. Fractions containing Dap-E12-W13 were collected,
concentrated by high vacuum, and lyophilized to give pure Dap-E12-
W13 as a white powder (4.3 mg, 10.7% yield based on resin loading):
2
mL). The mixture was filtered, and the resin was rinsed with an
additional cleavage cocktail. The combined filtrates were concentrated
+
+
to one-fourth the original volume using a stream of N gas. The
100 17
2
peptide was precipitated by adding cold ether (3 mL). The
precipitated peptide (white precipitate) was collected by centrifugation
for the analytical HPLC chromatogram and mass spectral data of
purified Dap-E12-W13.
Peptide 31. To a solution of N Trp(Boc)OH (0.660 g, 2.00
3
ASSOCIATED CONTENT
■
mmol) in dichloromethane (5 mL) was added diisopropylcarbodii-
mide (DIC, 0.154 mL, 1.00 mmol). The mixture was stirred for 1 h.
*
S
Supporting Information
33
ZThrGlyOBn (0.4 g, 1.0 mmol) and DMAP (0.012 g, 0.1 mmol)
were added, and the mixture was stirred for 24 h. The mixture was
filtered, and the filtrate wsa dissolved in Et O and washed with 0.25 M
2
1
13
31
NaOH, 0.1 M HCl, and saturated brine. The organic layer was dried
spectra, and HRMS data (PDF)
(
Na SO ) and concentrated, giving a yellow oil. The oil was subjected
2 4
to flash chromatography (30% EtOAc/70% hexane) which provided
1
peptide 31 as a white foam (0.606 g, 85% yield): H NMR (CDCl ) δ
3
8
6
5
.13 (1H, d, J = 7.9 Hz), 7.51−7.55 (2H, m), 6.87−7.32 (12H, m),
.89 (1H, t, J = 5.3 Hz), 5.68 (1H, d, J = 8.5 Hz), 4.48−5.51 (1H, m),
.13 (2H, s), 5.11 (2H, s), 4.48 (1H, d, J = 5.3 Hz), 4.23 (1H, t, J = 6.4
AUTHOR INFORMATION
■
Hz), 3.99 (2H, br s), 3.23 (1H, dd, J = 5.3, 14.8 Hz), 3.09 (1H, dd, J =
13
8
.5, 14.8 Hz), 1.65 (9H, s), 1.23 (3H, d, J = 6.4 Hz); C NMR
Notes
(
CDCl ) δ 169.2, 168.8, 168.7, 156.3, 149.4, 135.8, 135.3, 134.9, 129.9,
3
The authors declare no competing financial interest.
1
28.5, 128.2, 128.0, 124.6, 124.3, 122.5, 118.6, 115.3, 114.8, 83.7, 71.9,
+
6
7.4, 67.2, 61.7, 57.7, 41.3, 28.1, 27.1, 15.9; HRMS (m/z) [M + H]
calcd for C H O N 713.29295; found 713.29287.
Reaction of Peptide 31 with Phosphines in THF/H O. To a
solution of peptide 31 (0.02 g, 0.028 mmol) in THF (0.124 mL) and
37
41
9
6
ACKNOWLEDGMENTS
■
2
This research was supported by a Discovery Grant from the
Natural Sciences and Engineering Research Council (NSERC)
of Canada to S.D.T. (Grant No. 155283-2012).
H O (0.010 mL) was added a 1 M solution of PMe , PBu , or PPh in
2
3
3
3
THF (0.056 mL, 1.2 equiv). The mixture was stirred for 1 h for the
I
J. Org. Chem. XXXX, XXX, XXX−XXX